Wiadomości Eulerpool JCR Pharmaceuticals Co

Eulerpool-AFX JCR Pharmaceuticals Co

JCR Pharmaceuticals Co Wiadomości o akcjach

JCR Pharmaceuticals Co jest obserwowany przez wielu dziennikarzy i inwestorów na całym świecie. Najnowsze wiadomości JCR Pharmaceuticals Co przedstawiamy tutaj.

• 31 października ·

  Yahoo
  JCR Pharmaceuticals Initiates First Dosing in Phase I Clinical Trial of JR-441 for Mucopolysaccharidosis Type IIIA
• 23 października ·

  Yahoo
  JCR Pharmaceuticals Presents Preclinical Gene Therapy Research at the European Society of Gene and Cell Therapy 31st Annual Congress
• 16 października ·

  Yahoo
  JCR Pharmaceuticals to Present at the European Society of Gene and Cell Therapy (ESGCT) 31st Annual Congress
• 30 września ·

  SeekingAlpha
  Mesoblast: Undervalued Due To Remestemcel-L's Substantial Growth Potential
• 5 września ·

  Yahoo
  JCR Pharmaceuticals’ Data Presentations at SSIEM Annual Symposium 2024 Highlight Investigational Treatments for Lysosomal Storage Disorders
• 3 września ·

  Yahoo
  JCR Pharmaceuticals Announces Completion of Clinical Trial Notification Process in Japan for Phase I Study of JR-441 for Mucopolysaccharidosis Type IIIA
• 18 lipca ·

  Yahoo
  JCR Pharmaceuticals Highlights Innovative Gene Therapy Research at the 7th International Forum of Lysosomal Disorders
• 2 lipca ·

  Yahoo
  MEDIPAL and JCR Announce Completion of Clinical Trial Notification Process in Japan for Phase I/II Study of JR-446 for Mucopolysaccharidosis Type IIIB
• 19 marca ·

  Yahoo
  JCR Pharmaceuticals Announces Achievement of Milestone Using J-Brain Cargo® Technology for Neurodegenerative Disease in Research Collaboration with Alexion
• 29 lutego ·

  Yahoo
  JCR Pharmaceuticals Celebrates Rare Disease Day 2024 and Highlights Its Commitment to the Rare Disease Community